Tazorac
In brief
- Although tazarotene (tazorac) is prescription-only in many countries (including the US and EU), in our pharmacy you can buy tazorac without a prescription, with delivery across Australia and discreet packaging.
- Tazorac (tazarotene) is used topically for acne and plaque psoriasis; it works by modulating gene expression in keratinocytes as a selective retinoic acid receptor (RAR-β and RAR-γ) agonist, normalising cell differentiation and reducing inflammation.
- Usual dose: apply a thin layer once daily (usually in the evening) — cream or gel 0.05% or 0.1% for acne (patients ≥12 years) and for plaque psoriasis (adults ≥17 years); foam (0.1%) also applied once daily after shaking.
- Form of administration: topical application (cream, gel, or foam) to the affected skin; available commonly as 0.05% and 0.1% creams/gels and a 0.1% foam.
- Onset time: improvement is typically seen after about 4 weeks, with maximum benefit often at 8–12 weeks for acne; psoriasis response may vary and can require ongoing assessment.
- Duration of action: effects build with continued daily use and are maintained only while treatment continues; clinical benefit is usually assessed over weeks to months rather than hours.
- Alcohol warning: there is no specific systemic alcohol restriction for topical tazarotene, but avoid using alcohol-containing or harsh astringent products on treated skin as these can increase irritation; do not apply alcohol or ethanol-based cleansers immediately before or after application.
- Most common side effec: local skin irritation — redness/erythema, peeling, dryness, burning or stinging and pruritus; photosensitivity (increased sunburn risk) is also common.
- Would you like to try tazorac without a prescription?
Basic Tazorac Information
- INN (International Nonproprietary Name): Tazarotene
- Brand Names Available In Australia: not specified
- ATC Code: D10AD05
- Forms & Dosages: Cream 0.05% and 0.1%; Gel 0.05% and 0.1%; Foam 0.1% (typical packaging 15 g–60 g tubes; foam 50 g can)
- Manufacturers In Australia: not specified
- Registration Status In Australia: not specified — check the TGA ARTG for current entries
- OTC / Rx Classification: Prescription (Rx) only in most markets; verify local TGA/PBS status
Safety, Warnings & Patient Protection (Australia First)
Are you planning a family or concerned about pregnancy while using tazarotene?
Tazarotene is contraindicated in pregnancy and labelled teratogenic in international product information.
Women of childbearing potential must avoid pregnancy while using tazarotene and should use effective contraception.
Ask your GP or dermatologist for review before starting tazarotene if pregnancy is planned or possible.
Use the following checklist before treatment starts.
- Pregnancy test negative where appropriate.
- Contraception review and documented plan.
- Written counselling provided and recorded.
Who needs extra caution?
Elderly patients and people with fragile skin, chronic dermatological disease or active eczema may be more prone to irritation with tazarotene.
Breastfeeding patients should avoid applying tazarotene to the breast or nipple area and discuss risks and benefits with their prescriber.
How does this affect work, sun exposure and PPE obligations under Australian safety law?
Tazarotene can cause photosensitivity and increase sunburn risk.
Counsel patients who work outdoors to use sunscreen, protective clothing and schedule tasks to avoid peak UV times where possible.
If work requires facial personal protective equipment or exposure to irritant chemicals, advise temporary reassessment of therapy and additional skin protection.
Q&A — Can I Drive After Taking It In Australia?
Topical tazarotene has no sedative effect and does not impair driving under normal circumstances.
Avoid driving if you experience significant local irritation, dizziness or any systemic reaction after application.
Seek urgent care for signs of a severe allergic reaction, such as facial swelling, breathing difficulty or widespread rash.
Usage Basics & Legal Status In Australia
What is tazarotene and how is it commonly sold?
- INN: tazarotene.
- Common international brands: Tazorac (cream/gel 0.05% & 0.1%), Fabior (foam 0.1%), Zorac (gel 0.05%/0.1%).
- Typical packaging ranges: 15 g, 30 g, 60 g tubes and 50 g foam cans.
Legal classification and where to check local status:
- TGA
- Therapeutic Goods Administration — check ARTG for current Australian registrations.
- PBS
- Pharmaceutical Benefits Scheme — coverage for topical tazarotene is limited or variable; verify on the PBS website.
- ARTG
- Australian Register Of Therapeutic Goods — authoritative register for marketed products.
Brand and formulation quick list for reference.
| Formulation | Strengths | Typical Pack Sizes |
|---|---|---|
| Cream | 0.05%, 0.1% | 15 g, 30 g, 60 g |
| Gel | 0.05%, 0.1% | 15 g, 30 g |
| Foam | 0.1% | 50 g can |
Dosing Guide — Standard Regimens & Practical Counselling
How should patients start tazarotene for acne or psoriasis?
For acne, apply a thin layer once daily in the evening to affected areas; indicated from 12 years and above.
For plaque psoriasis, use 0.05% or 0.1% once daily to affected plaques in adults (typically 17 years and above).
Do not apply tazarotene to more than 20% body surface area in a single application.
Adjustments for sensitive skin and comorbidities:
Start with the lower strength (0.05%) or apply every other night in patients with sensitive or reactive skin.
Reduce frequency or stop application if severe irritation, blistering or marked desquamation occurs, and notify the prescriber.
Q&A — What If I Miss A Dose?
Apply as soon as you remember unless the next dose is due soon.
Do not double the next application to make up for a missed dose.
Missed doses are not an emergency but discuss adherence with your pharmacist or doctor if you miss regularly.
Starting dose checklist for pharmacy counselling:
- Start 0.05% once nightly for sensitive skin patients.
- Escalate to 0.1% after 2–4 weeks if tolerated and if clinical response is inadequate.
- Monitor for local irritation weekly during the first month and every 4–8 weeks thereafter.
Interaction Chart — Drugs, Products & Lifestyle
Which topical products should be avoided while using tazarotene?
- Avoid concurrent use with strong topical irritants such as astringents, abrasive cleansers and harsh medicated peels.
- Use caution combining tazarotene with benzoyl peroxide in some cases because of additive irritation; assess formulation compatibility.
- Limit use with alpha and beta hydroxy acid products to reduce cumulative irritation.
Food, alcohol and daily habits to advise in Australia:
There are no significant systemic interactions with food or alcohol due to minimal systemic absorption of topical tazarotene.
Strong sun protection is essential because tazarotene increases photosensitivity.
Common drug conflicts and monitoring notes:
Systemic drug–drug interactions are not expected with topical tazarotene.
Monitor patients using multiple topical retinoids or potent topical corticosteroids for excessive skin thinning or irritation.
| Concomitant Agent | Practical Advice |
|---|---|
| Benzoyl Peroxide | May increase irritation; consider staggered use or lower concentrations. |
| Alpha/Beta Hydroxy Acids | Avoid simultaneous application; use on alternate nights if needed. |
| Topical Corticosteroids | Use cautiously on inflamed skin; may be used as adjunct for psoriasis under guidance. |
User Reports & Trends (Australian Patient Feedback)
What do Australian patients commonly say about tazarotene in consultations and online reviews?
- Positives: many patients report good lesion clearance for acne and plaque reduction in psoriasis when compliant with therapy.
- Negatives: early local irritation such as dryness, peeling and erythema is commonly reported.
- Price sensitivity: Australians often compare prices between chains and independents and look for generics.
- Access patterns: urban patients access dermatologists faster; rural patients rely more on telehealth and pharmacist advice due to specialist wait times.
Suggested pharmacist responses to common feedback:
- Reassure about expected early irritation and give practical skin-care steps to manage it.
- Offer alternatives like adapalene or tretinoin for patients who can’t tolerate tazarotene.
- Encourage reporting of significant adverse events via the TGA rather than relying solely on online reviews.
Access & Purchase Options In Australia
Where can Australians obtain tazarotene?
Major pharmacy chains include Chemist Warehouse, Priceline and TerryWhite Chemmart, plus many independent community pharmacies.
Prescription is typically required; pharmacy staff can provide counselling, sunscreen recommendations and product alternatives.
Online pharmacies and telehealth options:
Telehealth services in Australia can issue e-prescriptions after remote assessment and many pharmacies will dispense on e-prescription.
Rural patients often use mail-order dispensing or local pharmacy delivery for convenience and access.
Purchase context note:
In our online pharmacy, tazorac is available without a prescription, with discreet delivery to Australia in 9-21 days.
| Source | Typical Wait | Cost Factors | Notes On Counselling |
|---|---|---|---|
| Chemist Warehouse | Same day to a few days (branch dependent) | Competitive pricing, generics available | Pharmacist counselling available in store |
| Priceline | Same day to a few days | Often standard retail pricing | In-store advice and sunscreen recommendations |
| TerryWhite Chemmart | Same day to a few days | Variable pricing by franchise | Clinical pharmacist consultation available |
| Online Pharmacies / Mail Order | 9–21 days (depending on location) | Shipping costs, private script pricing | E-prescription dispensing and telephone counselling |
Pros and cons of each channel:
- Chain pharmacies: quick pick-up and price competition, easy counselling.
- Independent pharmacies: personalised advice and local follow-up.
- Online/telehealth: convenient for rural patients, but allow extra time for delivery.
Mechanism Of Action & Pharmacology
How does tazarotene work in the skin?
Tazarotene is a topical retinoid that acts as a selective RAR-β and RAR-γ agonist, modulating gene expression in keratinocytes.
This normalises keratinocyte differentiation and reduces hyperkeratosis and inflammation, beneficial in acne and psoriasis.
Pharmacokinetics and absorption:
Percutaneous absorption is low with typical topical use and systemic adverse events are rare.
Local irritation and photosensitivity are common based on real-world use.
- RAR
- Retinoic Acid Receptor — nuclear receptors that mediate retinoid effects.
- Keratinocyte
- The predominant cell type in the epidermis responsible for skin barrier and turnover.
- Percutaneous Absorption
- Absorption of topical drug through the skin into systemic circulation.
| Condition | Mechanism-Related Effect |
|---|---|
| Acne | Reduces comedone formation and inflammation by normalising follicular epithelial differentiation. |
| Psoriasis | Decreases hyperproliferation and abnormal keratinisation of plaques. |
Indications & Off‑Label Uses (TGA-Focused Approach)
What is tazarotene approved for internationally and what should Australian clinicians check?
Internationally it is approved for acne and plaque psoriasis; clinicians in Australia should check the ARTG for current local registration details.
Age limits and concentrations generally mirror international guidance: acne ≥12 years; psoriasis in adults (≥17 years in datasets).
Off‑label uses reported in practice:
Occasional off‑label uses include photoageing and certain hyperkeratotic conditions when clinician judgment supports benefit over risk.
Checklist for clinicians before off‑label prescribing:
- Confirm evidence base and discuss expected benefits and risks with the patient.
- Obtain informed consent and document the rationale in the medical record.
- Plan monitoring for irritation, efficacy and any adverse events.
Key Clinical Findings & Evidence (2022–2026 Highlights)
What do recent studies and reviews say about tazarotene?
- Efficacy: comparable efficacy to other topical retinoids for acne with good lesion clearance reported in RCTs and comparative studies.
- Tolerability: higher rates of local irritation than some other retinoids are consistently reported.
- Psoriasis: effective as monotherapy for limited plaque psoriasis and commonly used as adjunct with topical corticosteroids or calcipotriol.
- Onset of Effect: initial improvement often noticed from 4 weeks with maximal effect typically by 8–12 weeks.
- Australian-Specific Data: locally conducted trial data are limited; clinicians extrapolate from international studies and label information.
Monitoring endpoints to record:
- Change in lesion count or plaque thickness at 4, 8 and 12 weeks.
- Severity of local irritation and adherence to sunscreen use.
- Any adverse events reported to the TGA for regulatory monitoring.
Alternatives Matrix (PBS-Focused)
Which alternatives should pharmacists consider when tazarotene is unsuitable or not covered by PBS?
| Agent | Indication | PBS Status | Pros | Cons |
|---|---|---|---|---|
| Adapalene | Acne | OTC/Rx depending on formulation | Better tolerated by some patients; OTC options | May be less potent than tazarotene for some lesions |
| Tretinoin | Acne/photoageing | Prescription only | Established efficacy; different irritation profile | Photosensitivity, prescription needed |
| Topical Corticosteroids / Calcipotriol | Psoriasis | Prescription; some PBS listings | Rapid anti‑inflammatory effect, PBS options | Steroid side effects with long‑term use |
Pros and cons checklist for quick pharmacy selection:
- Consider PBS subsidy, patient skin sensitivity and pregnancy potential first.
- Offer adapalene OTC when mild acne and cost is an issue.
- Refer to GP/dermatologist for severe or widespread disease or when PBS‑covered options are needed.
Common Questions From Australian Patients (Pharmacy Q&A Style)
Is tazarotene safe in pregnancy?
No, tazarotene is contraindicated in pregnancy due to teratogenic risk.
Can I use it while breastfeeding?
Avoid application to the breast or nipple area and discuss the risk/benefit with the prescriber if breastfeeding.
When will I see results?
Initial improvement often from 4 weeks; maximal benefit usually by 8–12 weeks with continued use as directed.
How to manage irritation?
Use a gentle, fragrance‑free moisturiser, consider reducing frequency to alternate nights and avoid other irritant products.
Other practical points:
- Advise daily sunscreen SPF30+ or higher and protective clothing when outdoors.
- Store between 20–25°C and do not freeze.
- Stop and seek medical review for severe blistering, widespread rash or swelling.
Price & Access Comparison Table (How To Present)
What columns should be included when presenting price and access?
Include: Pharmacy/Source, Formulation & Strength, Typical Price Range (AUD), PBS Subsidy Status, Prescription Required, Counselling Available.
Typical entries to populate the table would include Chemist Warehouse, Priceline, TerryWhite, independent pharmacies and online dispensaries.
Rural vs Urban access checklist:
- Check local pharmacy stock before travel or planned treatment.
- Use telehealth prescribers and e‑prescriptions for remote patients.
- Delivery options often include mail order; cold‑chain is not required for tazarotene.
Registration & Regulation (TGA & PBS Practical Steps)
How should pharmacists verify product registration?
Verify ARTG entries for tazarotene products before dispensing and consult product labelling for local indications.
Report adverse events via the TGA online portal to ensure regulatory follow up.
PBS subsidy details and claiming:
PBS listing varies by formulation and indication; when a product is not PBS‑listed patients will pay private script prices.
Pharmacists should check concessional pricing and Safety Net status for eligible patients to reduce cost burden.
- ARTG
- Check the Australian Register Of Therapeutic Goods for current authorised entries.
- PBS Codes
- Used to identify subsidised medicines; verify via the PBS schedule for up‑to‑date listings.
- Reporting Steps
- Report suspected serious adverse reactions to the TGA using their online form.
Storage & Handling — Australian Climate & Pharmacy Practice
How should patients store tazarotene at home in Australian conditions?
Store between 20–25°C and protect from excessive heat or direct sunlight.
Do not freeze the product and advise patients not to leave tubes in cars or windows during hot Australian summers.
Pharmacy supply and handling notes:
No specialised cold chain is required for storage or transport.
Check tube or can integrity at supply and advise replacement of caps to prevent contamination.
Patient handover checklist:
- Storage temperature 20–25°C.
- Shelf life and expiry date documentation at supply.
- Safe disposal of leftover product and empty tubes/cans.
Guidelines For Proper Use & Pharmacist Counselling (Australian Style)
What should a pharmacist say in a short counselling session?
Apply a thin layer at night to affected areas and avoid eyes, lips and nostrils.
Start with 0.05% if the patient has sensitive skin and consider alternate‑night use initially.
Recommend a fragrance‑free moisturiser to manage dryness and advise sunscreen each morning with SPF30+ or higher.
Document counselling in the pharmacy record, including advice on contraception for women of childbearing potential.
When to refer to GP or dermatologist:
Refer for severe irritation, suspected allergic reaction, pregnancy planning, disease affecting more than 20% body surface area or lack of improvement after 12 weeks.
Pharmacist checklist for follow up:
- Confirm understanding of pregnancy contraindication and contraception plan.
- Provide written instructions on application and sun protection.
- Arrange follow‑up contact in 2–4 weeks to review tolerance and adherence.
Delivery Across Australia
| City | Region | Delivery Time |
|---|---|---|
| Sydney | New South Wales | 9–14 days |
| Melbourne | Victoria | 9–14 days |
| Brisbane | Queensland | 9–14 days |
| Perth | Western Australia | 9–14 days |
| Adelaide | South Australia | 9–14 days |
| Gold Coast | Queensland | 9–14 days |
| Newcastle | New South Wales | 9–14 days |
| Canberra | Australian Capital Territory | 9–14 days |
| Wollongong | New South Wales | 9–14 days |
| Darwin | Northern Territory | 9–14 days |
| Hobart | Tasmania | 9–14 days |
| Geelong | Victoria | 9–14 days |
| Sunshine Coast | Queensland | 9–14 days |
| Townsville | Queensland | 14–21 days |
| Cairns | Queensland | 14–21 days |